JP2003079381A5 - - Google Patents

Info

Publication number

JP2003079381A5

JP2003079381A5 JP2001396686A JP2001396686A JP2003079381A5 JP 2003079381 A5 JP2003079381 A5 JP 2003079381A5 JP 2001396686 A JP2001396686 A JP 2001396686A JP 2001396686 A JP2001396686 A JP 2001396686A JP 2003079381 A5 JP2003079381 A5 JP 2003079381A5

Authority

JP

Japan

Prior art keywords

salt

seq

protein

partial peptide

dna

Prior art date

2001-12-27

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 108090000623 proteins and genes Proteins 0.000 claims 32
• 102000004169 proteins and genes Human genes 0.000 claims 32
• 150000003839 salts Chemical class 0.000 claims 29
• 108090000765 processed proteins & peptides Proteins 0.000 claims 23
• 239000002773 nucleotide Substances 0.000 claims 14
• 125000003729 nucleotide group Chemical group 0.000 claims 14
• 125000003275 alpha amino acid group Chemical group 0.000 claims 8
• 206010012601 diabetes mellitus Diseases 0.000 claims 8
• 239000000032 diagnostic agent Substances 0.000 claims 8
• 229940039227 diagnostic agent Drugs 0.000 claims 8
• 238000000034 method Methods 0.000 claims 8
• 239000002157 polynucleotide Substances 0.000 claims 8
• 102000040430 polynucleotide Human genes 0.000 claims 8
• 108091033319 polynucleotide Proteins 0.000 claims 8
• 208000031226 Hyperlipidaemia Diseases 0.000 claims 6
• 239000003814 drug Substances 0.000 claims 6
• 150000001875 compounds Chemical class 0.000 claims 5
• 238000012216 screening Methods 0.000 claims 5
• 230000000694 effects Effects 0.000 claims 4
• 102000054765 polymorphisms of proteins Human genes 0.000 claims 4
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 3
• 230000000069 prophylactic effect Effects 0.000 claims 3
• 229940124597 therapeutic agent Drugs 0.000 claims 3
• 108700008625 Reporter Genes Proteins 0.000 claims 1
• 238000003745 diagnosis Methods 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1